Latest / Stock Movers / Alibaba ADRs Fall, Novavax Rallies, Reddit Drops After Downgrade
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, Podcasts, Radio News, The Stock Movers Report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:13Speaker 1: harnessing the power of Bloomberg Data.
- 0:16Speaker 2: I'll think a look at some of the stocks on
- 0:18Speaker 2: the move today. I'm Alex Steel alongside Paul Sweeney and
- 0:20Speaker 2: we're joined now by Bloomberg. Zanita Zakova, you're looking at
- 0:23Speaker 2: Alibaba ad Rs.
- 0:25Speaker 3: What happened here?
- 0:26Speaker 2: Yeah, so Alibaba is having a tough day and Apple
- 0:28Speaker 2: is having a tough day. This is connected with the
- 0:31Speaker 2: deal that has been going for some time for Ali
- 0:35Speaker 2: Baba's Ai to be used on Eppo devices in China.
- 0:39Speaker 2: But now we're hearing a lot of scrutiny from White
- 0:42Speaker 2: House congressional officials and they're raising more and more concerns
- 0:46Speaker 2: about that deal. This is coming off the back on
- 0:50Speaker 2: the back of really tough earnings results from Ali Baba
- 0:55Speaker 2: and also after a few months of very elevated into
- 0:59Speaker 2: Seattle after what happened with Deep Seek, and we know
- 1:03Speaker 2: a lot of analysts were saying that Ali Baba will
- 1:05Speaker 2: be on one of the front runners of that AI boom,
- 1:10Speaker 2: especially when it comes to Chinese e commerce readers. So yes,
- 1:14Speaker 2: they were considered to be the leaders. There was so
- 1:17Speaker 2: much enthusiasm and now we're seeing a double wammy with
- 1:20Speaker 2: earnings results and a delay and potentially not happening deal
- 1:25Speaker 2: with Apple, and both stocks are struggling. People are saying
- 1:28Speaker 2: the partnership loss may be worse for Apple.
- 1:30Speaker 3: But we yet to see Novavax, another biotech company, which
- 1:35Speaker 3: again it's a binary situation. The drug hits, you make
- 1:39Speaker 3: a ton of money, it doesn't, it goes to zero.
- 1:41Speaker 3: What happens at Novovak.
- 1:42Speaker 2: Yeah, incredible vote this year. We've talked about it as
- 1:45Speaker 2: some of the big losers, some of the big winners.
- 1:47Speaker 2: Today obviously it's a big winning day. It jumped as
- 1:49Speaker 2: much as thirty percent. Now some of those games have faded,
- 1:52Speaker 2: but still thirteen percent. It's just incredible gain. It comes
- 1:56Speaker 2: off US regulators approving the vaccine for two main groups
- 2:01Speaker 2: that there was a lot of scrutiny there. So the
- 2:04Speaker 2: show is approved for adults over twenty over sixty five
- 2:08Speaker 2: and adults between twelve and sixty four who have at
- 2:12Speaker 2: least one underlying condition. So a lot of scrutiny was
- 2:17Speaker 2: coming from Robert.
- 2:21Speaker 1: F.
- 2:21Speaker 2: Kennedy. There was obviously a famous CBS interview, which after
- 2:26Speaker 2: which Novavax suffered a lot and it was not only Novavax,
- 2:29Speaker 2: it was a lot of those vaccine makers that have
- 2:31Speaker 2: a pretty tough start of the year. Now that said,
- 2:34Speaker 2: without approval, a lot of the other vaccine makers are
- 2:37Speaker 2: also seeing a lift, so there is some optimism after
- 2:40Speaker 2: a pretty rough start of the year. Novavax is down
- 2:43Speaker 2: just six percent this year, but it was down sixteen
- 2:46Speaker 2: percent just on Friday, so one day move makes a
- 2:49Speaker 2: big difference.
- 2:51Speaker 1: The Stock mover's report from Bloomberg Radio. Check back with
- 2:55Speaker 1: us throughout the day for the latest roundup of companies
- 2:58Speaker 1: making news on Wall Street. For the latest market moving headlines,
- 3:02Speaker 1: Listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg
- 3:06Speaker 1: dot com, and on Applecarplay and Android Auto with the
- 3:09Speaker 1: Bloomberg Business app.